Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (ABCG2, ABCB1) and gefitinib toxicity

作者: Yoshitsugu Horio , Yoshinori Hasegawa , Masashi Kondo , Maki Ando , Mihoko Horio

DOI: 10.18999/NAGJMS.74.1-2.133

关键词: RashGenotypeToxicityGefitinibInterstitial lung diseaseBiologyPharmacologyAllele frequencyAlleleInternal medicineLung cancerGastroenterology

摘要: The purpose of this study is to investigate associations between allelic variations ABCG2 and ABCB1 with skin toxicity, diarrhea, liver injury interstitial lung disease (ILD) in gefitinib-treated patients. A prospective clinical 83 Japanese patients non-small-cell cancer was performed. Polymorphic loci were genotyped, their effects on gefitinib toxicities evaluated. 34G>A statistically associated occurrence rash; 13 (42%) the 32 at least one variant allele (G/A A/A) developed grade 2 or worse rash, whereas only 10 (19%) 51 homozygous for reference (G/G) wild-type sequence both alleles did so (P=0.046). There no significant association severe polymorphisms 421C>A nor 3435C>T. results suggested that would be useful predicting rash.

参考文章(24)
Pengfei Song, Jatinder K. Lamba, Lijun Zhang, Erin Schuetz, Nikhil Shukla, Bernd Meibohm, Charles R. Yates, G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expression The Journal of Clinical Pharmacology. ,vol. 46, pp. 373- 379 ,(2006) , 10.1177/0091270005284387
Keiichi Akasaka, Takayuki Kaburagi, Shin’ichi Yasuda, Kyoko Ohmori, Kaori Abe, Hironori Sagara, Yoshihiko Ueda, Koshu Nagao, Johji Imura, Yasuo Imai, Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. ,vol. 66, pp. 691- 698 ,(2010) , 10.1007/S00280-009-1211-6
Danxin Wang, Andrew D. Johnson, Audrey C. Papp, Deanna L. Kroetz, Wolfgang Sadée, Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenetics and Genomics. ,vol. 15, pp. 693- 704 ,(2005) , 10.1097/01.FPC.0000178311.02878.83
Erin R Lepper, Kees Nooter, Jaap Verweij, Milin R Acharya, William D Figg, Alex Sparreboom, Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2. Pharmacogenomics. ,vol. 6, pp. 115- 138 ,(2005) , 10.1517/14622416.6.2.115
Sophie Sun, Joan H. Schiller, Adi F. Gazdar, Lung cancer in never smokers — a different disease Nature Reviews Cancer. ,vol. 7, pp. 778- 790 ,(2007) , 10.1038/NRC2190
Ho-Sook Kim, Yu Eun Sunwoo, Ji Young Ryu, Ho-Jin Kang, Hye-Eun Jung, Im-Sook Song, Eun-Young Kim, Joo-Cheol Shim, Ji-Hong Shon, Jae-Gook Shin, The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine British Journal of Clinical Pharmacology. ,vol. 64, pp. 645- 654 ,(2007) , 10.1111/J.1365-2125.2007.02944.X
Rando Allikmets, Michael Dean, Andrey Rzhetsky, The Human ATP-Binding Cassette (ABC) Transporter Superfamily Genome Research. ,vol. 11, pp. 1156- 1166 ,(2001) , 10.1101/GR.184901
Charis P Zamber, Jatinder K Lamba, Kazuto Yasuda, Jennifer Farnum, Kenneth Thummel, John D Schuetz, Erin G Schuetz, Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics. ,vol. 13, pp. 19- 28 ,(2003) , 10.1097/00008571-200301000-00004
Mitsuo Sato, David S. Shames, Adi F. Gazdar, John D. Minna, A Translational View of the Molecular Pathogenesis of Lung Cancer Journal of Thoracic Oncology. ,vol. 2, pp. 327- 343 ,(2007) , 10.1097/01.JTO.0000263718.69320.4C
Shinji Mizuarai, Naohiko Aozasa, Hidehito Kotani, Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2 International Journal of Cancer. ,vol. 109, pp. 238- 246 ,(2004) , 10.1002/IJC.11669